Home
Kristen Ambrose, SVP & Chief Accounting Officer: Vertex Pharmaceuticals VRTX Sell · Filed 02/26
Trade details
- Type
- Insider sale
- Amount
- $108,456.05
- Shares · price
- 223 sh · $486.35 a share
- Held after
- 6,981 sh
- Trade date
- 26/02/25
- Filed
- 26/02/26
- Days to filing
- 1 days
Sold 3.1% of holdings
- Share of holding sold
- 3.1%
Vertex Pharmaceuticals trades, last 26 weeks
What else happened in Vertex Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 01/26~03/27Kristen Ambrose's recent trades
- Kristen Ambrose
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$172.6K
357 sh
$172.6K
Filed 03/02
Traded 02/26
- Kristen Ambrose
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$762.1K
1,557 sh
$762.1K
Filed 02/19
Traded 02/17
- Kristen Ambrose
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$302.2K
638 sh
$302.2K
Filed 02/19
Traded 02/18
- Kristen Ambrose
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$633.6K
1,376 sh
$633.6K
Filed 02/12
Traded 02/11
- Kristen Ambrose
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$425.2K
884 sh
$425.2K
Filed 25/02/26
Traded 25/02/25